Efg Asset Management (North America) Corp. Exact Sciences Corp Transaction History
Efg Asset Management (North America) Corp.
- $671 Million
- Q2 2025
A detailed history of Efg Asset Management (North America) Corp. transactions in Exact Sciences Corp stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 65,775 shares of EXAS stock, worth $2.7 Million. This represents 0.52% of its overall portfolio holdings.
Number of Shares
65,775
Previous 38,385
71.36%
Holding current value
$2.7 Million
Previous $1.66 Million
110.42%
% of portfolio
0.52%
Previous 0.29%
Shares
13 transactions
Others Institutions Holding EXAS
# of Institutions
638Shares Held
160MCall Options Held
1.64MPut Options Held
1.5M-
Capital World Investors Los Angeles, CA17.8MShares$731 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$723 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$512 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$495 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$271 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.25B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...